A detailed history of Sculptor Capital LP transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Sculptor Capital LP holds 370,400 shares of AVXL stock, worth $4.14 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
370,400
Previous 370,400 -0.0%
Holding current value
$4.14 Million
Previous $1.56 Million 34.55%
% of portfolio
0.08%
Previous 0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$4.55 - $6.75 $1.69 Million - $2.5 Million
370,400 New
370,400 $1.89 Million

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $871M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Sculptor Capital LP Portfolio

Follow Sculptor Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Sculptor Capital LP with notifications on news.